Balance Sheet
Accounts PayablesAccumulated DepreciationAssetsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

60 Degrees Pharmaceuticals (SXTP) Inventory (2022 - 2025)

60 Degrees Pharmaceuticals (SXTP) has disclosed Inventory for 4 consecutive years, with $771686.0 as the latest value for Q3 2025.

  • On a quarterly basis, Inventory rose 70.71% to $771686.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $771686.0, a 70.71% increase, with the full-year FY2024 number at $442764.0, down 5.02% from a year prior.
  • Inventory was $771686.0 for Q3 2025 at 60 Degrees Pharmaceuticals, down from $799421.0 in the prior quarter.
  • In the past five years, Inventory ranged from a high of $799421.0 in Q2 2025 to a low of $426020.0 in Q2 2024.
  • A 4-year average of $598651.1 and a median of $598319.0 in 2023 define the central range for Inventory.
  • Peak YoY movement for Inventory: crashed 42.52% in 2024, then skyrocketed 87.65% in 2025.
  • 60 Degrees Pharmaceuticals' Inventory stood at $678916.0 in 2022, then plummeted by 31.34% to $466169.0 in 2023, then decreased by 5.02% to $442764.0 in 2024, then surged by 74.29% to $771686.0 in 2025.
  • Per Business Quant, the three most recent readings for SXTP's Inventory are $771686.0 (Q3 2025), $799421.0 (Q2 2025), and $773238.0 (Q1 2025).